Breaking News

Glaxo to Pay $488.7 Million Fine to End China Corruption Probe
Tweet TWEET

Evolva shareholders approve all Board proposals in AGM

NEWS RELEASE Evolva shareholders approve all Board proposals in AGM

Reinach, Switzerland, 7 May 2013 - The Annual General Meeting of Evolva
Holding SA (SIX: EVE) has approved all proposals put forward by the Board of
Directors.

A total of 123 shareholders were present at the meeting which took place in
Basel today. 72,396,063 shares were represented, or 29.96% of the total number
of shares issued (241,620,105). A detailed overview of the agenda items and
the proposals is available on the Evolva website.

- ends -

About Evolva

Evolva's mission is to discover and provide innovative, sustainable
ingredients for health, nutrition and wellness. Evolva uses biosynthetic and
evolutionary technologies to create and optimise small molecule compounds and
their production routes. We are active in consumer healthcare and nutrition as
well as in pharma. In both areas we have partnered projects as well as
proprietary programmes. For more information see www.evolva.com.

Contact Details

Neil Goldsmith, CEO      Jakob Dynnes Hansen, CFO      Paul Verbraeken, IR
neilg@evolva.com         jakobdh@evolva.com            paulv@evolva.com
+ 41 61 485 2005         + 41 61 485 2034              + 41 61 485 2035

This press release contains specific forward-looking statements, e.g.
statements including terms like believe, assume, expect or similar
expressions. Such forward-looking statements are subject to known and unknown
risks, uncertainties and other factors which may result in a substantial
divergence between the actual results, financial situation, development or
performance of the company and those explicitly or implicitly presumed in
these statements. Against the background of these uncertainties readers should
not place undue reliance on forward-looking statements. The company assumes no
responsibility to update forward-looking statements or to adapt them to future
events or developments.

PDF

Provider                  Channel         Contact
Tensid Ltd., Switzerland  newsbox.ch      Provider/Channel related enquiries
www.tensid.ch             www.newsbox.ch  marco@tensid.ch
                                          +41 41 763 00 50
 
Press spacebar to pause and continue. Press esc to stop.